Autotaxin, bile acid profile and effect of IBAT inhibition in primary biliary cholangitis patients with pruritus

Autor: Hegade, VS, Pechlivanis, A, McDonald, JA, Rees, D, Corrigan, M, Hirschfield, GM, Taylor-Robinson, SD, Holmes, E, Marchesi, JR, Kendrick, S, Jones, DE

BACKGROUND &AIMS: Pruritus is a common symptom in patients with primary biliary cholangitis (PBC) for which ileal bile acid transporter (IBAT) inhibition is emerging as a potential therapy. We explored the serum metabonome and gut microbiota profile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::5c099697b0e682efbf796d4300410e57
http://hdl.handle.net/10044/1/67152

Advances in coeliac disease.

Autor: Armstrong MJ, Hegade VS, Robins G

Publikováno v: Current Opinion in Gastroenterology; 2012 Mar, Vol. 28 Issue 2, p104-112, 9p

Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitis.

Autor: Ahmed W; Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Joshi D; Gastroenterology, King's College Hospital Liver Unit, London, UK., Huggett MT; Gastroenterology, St James's University Hospital, The Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK., Everett SM; Gastroenterology, St James's University Hospital NHS Trust, Leeds, UK., James M; Gastroenterology, Nottingham University, Nottingham, UK., Menon S; Department of Hepatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Oppong KW; HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK., On W; Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Paranandi B; Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Trivedi P; National Institute for Health Research, Centre for Liver Research, University Hospitals Birmingham, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Webster G; Department of Gastroenterology, University College London Hospital NHS Foundation Trust, London, UK., Hegade VS; Leeds Liver Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Publikováno v: Frontline gastroenterology [Frontline Gastroenterol] 2023 Sep 12; Vol. 15 (1), pp. 74-83. Date of Electronic Publication: 2023 Sep 12 (Print Publication: 2024).

Intraductal fully covered self-expanding metal stents in the management of post-liver transplant anastomotic strictures: a UK wide experience.

Autor: Ahmed W; Institute for Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK., Kyle D; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK., Khanna A; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK., Devlin J; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK., Reffitt D; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK., Zeino Z; Southmead Hospital/North Bristol NHS Trust, Bristol, UK., Webster G; Hepatopancreatobiliary Unit, University College Hospital, London, UK., Phillpotts S; Hepatopancreatobiliary Unit, University College Hospital, London, UK., Gordon R; Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge, UK., Corbett G; Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge, UK., Gelson W; Cambridge Liver Unit, Addenbrooke's Hospital, Cambridge, UK., Nayar M; Freeman Hospital, Newcastle upon Tyne, UK., Khan H; Southwest Liver Unit and Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK., Cramp M; Southwest Liver Unit and Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK., Potts J; Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital and UCL Institute of Liver and Digestive Health, London, UK., Fateen W; Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital and UCL Institute of Liver and Digestive Health, London, UK., Miller H; Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital and UCL Institute of Liver and Digestive Health, London, UK., Paranandi B; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Huggett M; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Everett SM; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Hegade VS; Leeds Teaching Hospitals NHS Trust, Leeds, UK., O'Kane R; Belfast Health and Social Care Trust, Belfast, UK., Scott R; Belfast Health and Social Care Trust, Belfast, UK., McDougall N; Belfast Health and Social Care Trust, Belfast, UK., Harrison P; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK., Joshi D; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.

Publikováno v: Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2022 Sep 26; Vol. 15, pp. 17562848221122473. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

Autor: Barron-Millar B; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Ogle L; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Mells G; Department of Human Genetics, University of Cambridge, Cambridge, United Kingdom., Flack S; Department of Human Genetics, University of Cambridge, Cambridge, United Kingdom., Badrock J; Department of Human Genetics, University of Cambridge, Cambridge, United Kingdom., Sandford R; Department of Human Genetics, University of Cambridge, Cambridge, United Kingdom., Kirby J; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Palmer J; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Jopson L; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Brain J; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Smith GR; Bioinformatics Support Unit (BSU), Newcastle University, Newcastle-upon-Tyne, United Kingdom., Rushton S; School of Natural and Environmental Science, Newcastle University, Newcastle-upon-Tyne, United Kingdom., Hegade VS; Liver Unit, St James' Hospital, Leeds, United Kingdom., Jones R; Liver Unit, St James' Hospital, Leeds, United Kingdom., Rushbrook S; Norfolk and Norwich University Hospital, Norwich, United Kingdom., Thorburn D; Liver Unit, Royal Free Hospital, London, United Kingdom., Ryder S; Queen's Medical Centre, Nottingham, United Kingdom., Hirschfield G; Queen Elizabeth Hospital, Birmingham, United Kingdom.; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada., Dyson JK; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom.; Freeman Hospital, Newcastle-upon-Tyne, United Kingdom., Jones DEJ; Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom.; Freeman Hospital, Newcastle-upon-Tyne, United Kingdom.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2021 Dec; Vol. 74 (6), pp. 3269-3283. Date of Electronic Publication: 2021 Nov 02.